Search
for
Sort by
Research 601–630 of 1000+
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
- Update on medical management of benign prostatic hyperplasia
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- 8주 지구성 훈련이 랫 전립선의 자가포식과 전립선비대증에 미치는 영향
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
- Les Visiteurs des malades
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- 5α‐Reductase inhibitors and prostatic disease
- 황금(黃芩)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향
- Reply to finasteride and dutasteride may reduce melanoma risk
- Clinical research on preoperative application of finasteride in reducing transurethral resection syndrome
- Effects of Castration on BPH
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Associations between semen quality and lower urinary tract symptoms in ageing male
- 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy
- Finasteride treatment and neuroactive steroid formation.
- Клинико-морфологическая характеристика ПЖ на фоне лечения ингибиторами 5-альфаредуктазы при ДГПЖ
- Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование
- Clinical application of 5α-reductase inhibitors
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- Comparison of clinical trials with finasteride and dutasteride.
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study